Email this page
Print
Bookmark and share
Bigger
Smaller
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Articles on allergy & anaphylaxis drugs from NPS RADARArticles on allergy & anaphylaxis drugs from NPS RADAR
| Title | Content Type | Date | Description |
|---|---|---|---|
| Anaphylaxis management plan | Professional publication - NPS RADAR - Web only item | 2010-08-01 00:00:00 | Anaphylaxis management plans and Adrenaline autoinjector (Anapen) for acute allergic anaphylaxis |
| ASCIA guidelines for prescribing an adrenaline autoinjector | Professional publication - NPS RADAR - Web only item | 2010-08-01 00:00:00 | ASCIA guidelines for prescribing an adrenaline autoinjector |
| Adrenaline autoinjector (Anapen) for acute allergic anaphylaxis | Professional publication - NPS RADAR - Review | 2010-08-01 00:00:00 | Anapen is a new autoinjector for the emergency treatment of anaphylaxis. It has a substantially different administration technique to that of EpiPen. |
| Adrenaline autoinjector (EpiPen) for acute allergic anaphylaxis | Professional publication - NPS RADAR - Review | 2006-08-01 00:00:00 | Reviews change to PBS listing allowing immediate prescription of adrenaline autoinjectors after hospital treatment for acute allergic anaphylaxis, and describes management plans and patient education. |
| Pseudoephedrine on prescription | Professional publication - NPS RADAR - Brief item | 2006-08-01 00:00:00 | Pack sizes containing pseudoephedrine 800 mg in liquid form or 720 mg in solid form are now prescription-only, a change designed to mitigate diversion of pseudoephedrine to the synthesis of methamphetamine. |
View all RADAR articles by date, by therapeutic topic, or by active ingredient, or find out more about NPS RADAR.
NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-28 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
